U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H17FN6O2
Molecular Weight 428.4185
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BALIPODECT

SMILES

COC1=CN(N=C(C2=CC=NN2C3=CC=CC=C3)C1=O)C4=CC=C(C=C4F)N5C=CC=N5

InChI

InChIKey=KVHRYLNQDWXAGI-UHFFFAOYSA-N
InChI=1S/C23H17FN6O2/c1-32-21-15-29(19-9-8-17(14-18(19)24)28-13-5-11-25-28)27-22(23(21)31)20-10-12-26-30(20)16-6-3-2-4-7-16/h2-15H,1H3

HIDE SMILES / InChI

Molecular Formula C23H17FN6O2
Molecular Weight 428.4185
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 08:39:56 UTC 2023
Edited
by admin
on Sat Dec 16 08:39:56 UTC 2023
Record UNII
6650W303H0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BALIPODECT
INN  
INN  
Official Name English
1-(2-FLUORO-4-(1H-PYRAZOL-1-YL)PHENYL)-5-METHOXY- 3-(1-PHENYL-1H-PYRAZOL-5-YL)PYRIDAZIN-4(1H)-ONE
Systematic Name English
TAK-063
Code English
BALIPODECT [USAN]
Common Name English
4(1H)-PYRIDAZINONE, 1-(2-FLUORO-4-(1H-PYRAZOL-1-YL)PHENYL)-5-METHOXY-3-(1-PHENYL-1H-PYRAZOL-5-YL)-
Systematic Name English
Balipodect [WHO-DD]
Common Name English
balipodect [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 689219
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
EU-Orphan Drug EU/3/19/2154
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
FDA ORPHAN DRUG 689319
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
Code System Code Type Description
USAN
EF-96
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
CAS
1238697-26-1
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
PUBCHEM
46848915
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
FDA UNII
6650W303H0
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
NCI_THESAURUS
C166905
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
DRUG BANK
DB14774
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
SMS_ID
100000178413
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
INN
10456
Created by admin on Sat Dec 16 08:39:56 UTC 2023 , Edited by admin on Sat Dec 16 08:39:56 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Its selectivity over other PDEs could be up to 15 000-fold. Its pharmacokinetics were promising, including high brain penetration in mice
IC50
Related Record Type Details
ACTIVE MOIETY